| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.01 |